share_log

诺唯赞(688105.SH)子公司与上海医药附属就阿尔茨海默病血检产品等业务达成合作

A subsidiary of Novizan (688105.SH) and a subsidiary of Shanghai Pharmaceutical reached a cooperation on businesses such as Alzheimer's disease blood test products

Zhitong Finance ·  May 10 17:51

Novi Zan (688105.SH) announced that Nanjing Novi Zan Medical Technology Co., Ltd., a wholly-owned subsidiary of the company (“Novi...

Zhitong Finance App News, Novi Zan (688105.SH) announced that Nanjing Novi Zan Medical Technology Co., Ltd. (“Novi Zan Medical”), a wholly-owned subsidiary of the company, recently signed a “Cooperation Agreement” with Shangyao Kangdelle (Shanghai) Pharmaceutical Co., Ltd. (“Shanghai Kangdler”) on business cooperation matters such as the company's Alzheimer's disease (AD blood test products).

According to the announcement, Shanghai Pharmaceutical Kangdele is an enterprise directly under Shanghai Pharmaceutical Holdings Co., Ltd. (“Shanghai Pharmaceutical Holdings”) under Shanghai Pharmaceutical Group Co., Ltd. (601607.SH, 02607.HK).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment